On May 29, 2019 Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, reported that it will present at the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5, 2019, at 2:00 p.m. Eastern Time (Press release, Odonate Therapeutics, MAY 29, 2019, View Source [SID1234536656]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On May 29, 2019 Genomic Health, Inc. (NASDAQ: GHDX) reported that management will present at the Jefferies 2019 Healthcare Conference in New York City on Wednesday, June 5, 2019 at 2 p.m. Eastern Time (Press release, Genomic Health, MAY 29, 2019, View Source [SID1234536655]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To access the live and subsequently archived webcast of the presentation, go to the Investor Relations section of the company’s web site at View Source Please connect to the web site at least 15 minutes prior to the presentation to allow for any software download that may be necessary. An archived replay will be available for three months beginning 24 hours after the live presentation.

On May 29, 2019 Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease, reported that John P. Butler, President and Chief Executive Officer of Akebia, will participate in the following investor conferences (Press release, Akebia, MAY 29, 2019, View Source [SID1234536654]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Jefferies 2019 Healthcare Conference on Tuesday, June 4th at 3:00 p.m. Eastern Time at the Grand Hyatt New York.
The Raymond James Life Sciences and MedTech Conference on Wednesday, June 19th at 10:55 a.m. Eastern Time at the Lotte New York Palace.
A live webcast of the presentations will be available on the company’s website at www.akebia.com. A replay of the webcast will be available on Akebia’s website following the conference.

On May 29, 2019 CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, reported that Samarth Kulkarni, Ph.D., Chief Executive Officer of CRISPR Therapeutics, is scheduled to present at the following investor conferences in June (Press release, CRISPR Therapeutics, MAY 29, 2019, View Source [SID1234536653]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies 2019 Healthcare Conference
Date: Tuesday, June 4, 2019
Presentation: 11:30 a.m. ET
Location: New York, NY

Goldman Sachs 40th Annual Global Healthcare Conference
Date: Wednesday, June 12, 2019
Presentation: 8:40 a.m. PT
Location: Rancho Palos Verdes, CA

A live webcast of the events will be available on the "Events & Presentations" page in the Investors section of the Company’s website at View Source A replay of the webcasts will be archived on the Company’s website for 14 days following each presentation.

On May 29, 2019 Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, reported that its Chief Executive Officer, Dr. Adi Hoess, will present at the Jefferies 2019 Healthcare Conference on Wednesday, June 5, 2019 at 10:00 a.m. Eastern Time (Press release, Affimed, MAY 29, 2019, View Source [SID1234536652]). A live webcast of the presentation can be accessed under the "News & Events" section of Affimed’s website at View Source and will be available for 30 days following the event.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!